🇺🇸 Anti-Thymocyte Globulins in United States
2 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 22 April 2025 – 22 April 2026
- Total reports: 2
Most-reported reactions
- Solid Organ Transplant Rejection — 2 reports (100%)
Frequently asked questions
Is Anti-Thymocyte Globulins approved in United States?
Anti-Thymocyte Globulins does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for Anti-Thymocyte Globulins in United States?
Tianjin First Central Hospital is the originator. The local marketing authorisation holder may differ — check the official source linked above.